Status:
COMPLETED
Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Bladder, Neurogenic
Eligibility:
All Genders
2-16 years
Phase:
PHASE2
PHASE3
Brief Summary
Aim of this study is to evaluate the efficacy and safety of a range of doses of tamsulosin hydrochloride as treatment in children with an elevated detrusor leak point pressure associated with a known ...
Eligibility Criteria
Inclusion
- Neuropathic bladder secondary to a known neurologic deficit (e.g. spina bifida)
- Elevated detrusor leak point pressures (LPP) ≥40 cm H2O confirmed by two measurements
Exclusion
- Clinically significant abnormalities as determined by the investigator
- A history of relevant orthostatic hypotension, fainting spells or blackouts
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
231 Patients enrolled
Trial Details
Trial ID
NCT00796614
Start Date
January 1 2008
End Date
February 1 2009
Last Update
October 29 2015
Active Locations (52)
Enter a location and click search to find clinical trials sorted by distance.
1
Los Angeles, California, United States, 90027
2
Tampa, Florida, United States, 33614
3
St Louis, Missouri, United States, 63110
4
Buffalo, New York, United States, 14222